5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Analyze DCF forecasts for the company and compare them with competitors.
1.99B
Revenue has increased from the previous period.
1.35%
Revenue growth rate is unchanged from the previous period.
295.81M
EBITDA has increased from the previous period.
14.83%
EBITDA margin is unchanged from the previous period.
207.44M
EBIT has increased from the previous period.
10.40%
EBIT margin is unchanged from the previous period.
88.37M
Depreciation has increased from the previous period.
290.45M
Total cash has increased from the previous period.
14.56%
Cash percentage is unchanged from the previous period.
291.94M
Receivables have increased from the previous period.
14.64%
Receivables percentage is unchanged from the previous period.
380.70M
Inventories have increased from the previous period.
19.09%
Inventory percentage is unchanged from the previous period.
222.53M
Accounts payable has increased from the previous period.
11.16%
Payables percentage is unchanged from the previous period.
-181.92M
Capital expenditure has increased from the previous period.
-9.12%
CapEx percentage is unchanged from the previous period.
6.20%
WACC is unchanged from the previous period.
6.93%
Cost of equity is unchanged from the previous period.
4.59%
Cost of debt is unchanged from the previous period.
0.50
Beta is unchanged from the previous period.
354.75M
Diluted shares outstanding is unchanged from the previous period.
438.10M
Total debt is unchanged from the previous period.
1.49B
Total equity is unchanged from the previous period.
1.92B
Total capital is unchanged from the previous period.
22.76%
Debt weighting is unchanged from the previous period.
77.24%
Equity weighting is unchanged from the previous period.
167.53M
EBIAT has increased from the previous period.
67.98M
UFCF has increased from the previous period.
1.00%
Long-term growth rate is unchanged from the previous period.
1.38B
Terminal value is unchanged from the previous period.
1.22B
Enterprise value is unchanged from the previous period.
146.50M
Net debt is unchanged from the previous period.
1.07B
Equity value is unchanged from the previous period.
3.01
Equity value per share is unchanged from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
2.20B
The estimated revenue has increased from the previous period.
326.93M
The estimated EBITDA has increased from the previous period.
0.47
The estimated EPS has increased from the previous period.
168.44M
The estimated net income has increased from the previous period.
229.26M
The estimated EBIT has increased from the previous period.
143.84M
The estimated SG&A expenses have increased from the previous period.
